XML 87 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of basic and diluted earnings per share, impact of two-class method
The following table summarizes the impact of the two-class method:
Three months ended
September 30,		Nine months ended
September 30,
(in millions, except per share data)2025202420252024
Basic EPS
Net earnings attributable to AbbVie Inc.$186 $1,561 $2,410 $4,300 
Earnings allocated to participating securities10 10 30 30 
Earnings available to common shareholders$176 $1,551 $2,380 $4,270 
Weighted-average basic shares outstanding1,769 1,769 1,769 1,769 
Basic earnings per share attributable to AbbVie Inc.$0.10 $0.88 $1.35 $2.41 
Diluted EPS
Net earnings attributable to AbbVie Inc.$186 $1,561 $2,410 $4,300 
Earnings allocated to participating securities10 10 30 30 
Earnings available to common shareholders$176 $1,551 $2,380 $4,270 
Weighted-average shares of common stock outstanding1,769 1,769 1,769 1,769 
Effect of dilutive securities3 3 3 3 
Weighted-average diluted shares outstanding1,772 1,772 1,772 1,772 
Diluted earnings per share attributable to AbbVie Inc.$0.10 $0.88 $1.34 $2.41